Liquidia Technologies, Inc. $LQDA Shares Sold by Deutsche Bank AG

Deutsche Bank AG cut its stake in Liquidia Technologies, Inc. (NASDAQ:LQDA) by 10.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 45,670 shares of the company’s stock after selling 5,405 shares during the quarter. Deutsche Bank AG owned about 0.05% of Liquidia Technologies worth $674,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of LQDA. Cetera Investment Advisers increased its position in shares of Liquidia Technologies by 4.3% during the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company’s stock worth $367,000 after purchasing an additional 1,277 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Liquidia Technologies during the 4th quarter worth about $218,000. Millennium Management LLC acquired a new stake in shares of Liquidia Technologies during the 4th quarter worth about $526,000. GAMMA Investing LLC increased its position in shares of Liquidia Technologies by 2,342.7% during the 1st quarter. GAMMA Investing LLC now owns 43,675 shares of the company’s stock worth $644,000 after purchasing an additional 41,887 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Liquidia Technologies by 31.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 24,623 shares of the company’s stock worth $290,000 after purchasing an additional 5,945 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Liquidia Technologies Stock Performance

NASDAQ LQDA opened at $26.25 on Tuesday. The company has a market cap of $2.26 billion, a P/E ratio of -15.44 and a beta of 0.14. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The stock has a 50-day moving average of $17.76 and a two-hundred day moving average of $16.04. Liquidia Technologies, Inc. has a 1-year low of $8.75 and a 1-year high of $28.00.

Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($0.06). The company had revenue of $8.84 million during the quarter, compared to analysts’ expectations of $3.90 million. Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The company’s revenue was up 141.5% on a year-over-year basis. As a group, analysts anticipate that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. BTIG Research reissued a “buy” rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Raymond James Financial raised their price objective on Liquidia Technologies from $33.00 to $41.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, August 13th. Wells Fargo & Company raised their price objective on Liquidia Technologies from $25.00 to $31.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 13th. Oppenheimer set a $13.00 price objective on Liquidia Technologies and gave the stock an “underperform” rating in a research report on Monday, May 19th. Finally, Needham & Company LLC lifted their target price on Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, August 12th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $32.11.

Insiders Place Their Bets

In other news, insider Rajeev Saggar sold 5,327 shares of Liquidia Technologies stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $76,069.56. Following the completion of the transaction, the insider owned 271,413 shares in the company, valued at approximately $3,875,777.64. This trade represents a 1.92% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Scott Moomaw sold 4,797 shares of Liquidia Technologies stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $14.28, for a total value of $68,501.16. Following the completion of the transaction, the insider owned 223,231 shares of the company’s stock, valued at $3,187,738.68. The trade was a 2.10% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 90,277 shares of company stock worth $1,469,392. Corporate insiders own 30.10% of the company’s stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).